๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Maxigen Biotech Inc. (TPE:1783)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
31.80
-2.00 (-5.92%)
Nov 20, 2026, 1:30 PM CST

Maxigen Biotech Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
856.96811.56680.65622.12604.43511.98
Revenue Growth
8.13%19.23%9.41%2.93%18.06%11.86%
Gross Profit
608.85563.72483.33424.09373.99261.03
Operating Income
281.37261.04179.91149.85128.6289.95
Net Income
303.01265.31190.17165.83139.487.67
Earnings Per Share
3.352.942.121.851.561.04
EPS Growth
29.32%38.68%14.59%18.59%50.28%31.75%

Revenue by Segment

Fiscal Year
FY 2025FY 2024
Period EndingDec '25 Dec '24
Taiwan
322.95303.33
Asia
154.27121.78
Europe and America
328.86255.54
Other Regions
5.48-
Total
811.56680.65

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
764.99876.19639.05431.08799.76527.15
Total Debt
-100---9.64
Net Cash (Debt)
764.99776.19639.05431.08799.76517.51
Net Cash Growth
4.63%21.46%48.24%-46.10%54.54%161.86%
Net Cash Per Share
8.448.597.124.828.956.12

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
298.38290.22298.22171.2268.34117.59
Capital Expenditures
-73.82-81.87-31.77-22.44-14.29-14.26
Free Cash Flow
224.56208.36266.45148.76254.05103.34
Free Cash Flow Growth
0.46%-21.80%79.12%-41.44%145.85%61.91%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
71.05%69.46%71.01%68.17%61.88%50.98%
Operating Margin
32.83%32.16%26.43%24.09%21.28%17.57%
Pretax Margin
38.75%37.57%33.14%31.05%27.43%19.04%
Profit Margin
35.36%32.69%27.94%26.66%23.06%17.12%
FCF Margin
26.21%25.67%39.15%23.91%42.03%20.18%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22
Dividend Per Share
2.0002.0000.8301.0000.476
Dividend Per Share Growth
140.93%140.96%-17.00%110.00%-
Dividend Yield
6.29%4.67%1.70%2.07%1.05%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
9.4914.4722.9525.9628.9545.59
Forward PE
-10.5310.5310.5310.5310.53
P/FCF Ratio
12.7018.4216.3828.9415.8938.67
PS Ratio
3.334.736.416.926.687.81